Fu Ou‐Yang
Impact in
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
Papers in
-
- Bioactive Compounds and Antitumor Agents 6
- Oncology 10
- Co-authors
- Mien‐Chie Hung (5 shared papers)Ming‐Feng Hou (22 shared papers)Weiya Xia (3 shared papers)Dung‐Fang Lee (3 shared papers)Jer-Yen Yang (2 shared papers)Leonard S. Golfman (2 shared papers)Norihisa Hanada (2 shared papers)Mickey C.‐T. Hu (2 shared papers)
- Journals
- Antioxidants (3 papers)Environmental Toxicology (3 papers)BMC Cancer (2 papers)Cell (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- TaiwanUnited StatesPakistan
In The Last Decade
Fu Ou‐Yang
42 papers receiving 2k citations
Fu Ou‐Yang's Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 247
- Oncology 348
- Molecular Biology 897
- Aging 20
- Drug Discovery 3
Countries citing papers authored by Fu Ou‐Yang
This map shows the geographic impact of Fu Ou‐Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Ou‐Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Ou‐Yang more than expected).
Fields of papers citing papers by Fu Ou‐Yang
This network shows the impact of papers produced by Fu Ou‐Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Ou‐Yang. The network helps show where Fu Ou‐Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu Ou‐Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a Hit paper breakdown → | 2004 | 781 |
| 2 | 2004 | 249 | |
| 3 | 2018 | 190 | |
| 4 | 2006 | 117 | |
| 5 | 2018 | 53 | |
| 6 | 2006 | 52 | |
| 7 | 2021 | 48 | |
| 8 | 2002 | 46 | |
| 9 | 2020 | 35 | |
| 10 | 2019 | 34 | |
| 11 | 2010 | 31 | |
| 12 | 2004 | 28 | |
| 13 | 2019 | 28 | |
| 14 | 2021 | 27 | |
| 15 | 2022 | 27 | |
| 16 | 2020 | 26 | |
| 17 | 2019 | 21 | |
| 18 | 2020 | 21 | |
| 19 | 2020 | 21 | |
| 20 | 2020 | 20 |
About Fu Ou‐Yang
Fu Ou‐Yang is a scholar working on Toxicology, Oncology, Complementary and alternative medicine, Molecular Biology and Cancer Research, having authored 42 papers that have together received 2k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (6 papers), Cell death mechanisms and regulation (4 papers), Medicinal Plant Research (4 papers), Phytochemical Studies and Bioactivities (4 papers), Phytochemicals and Medicinal Plants (3 papers), Breast Lesions and Carcinomas (3 papers), Breast Cancer Treatment Studies (3 papers) and Mechanisms of cancer metastasis (2 papers). The work is most often cited by research in Cancer Research (247 citations), Oncology (348 citations), Molecular Biology (897 citations), Aging (20 citations) and Drug Discovery (3 citations). Fu Ou‐Yang has collaborated with scholars based in Taiwan, United States and Pakistan. Frequent co-authors include Mien‐Chie Hung, Ming‐Feng Hou, Weiya Xia, Dung‐Fang Lee, Jer-Yen Yang, Leonard S. Golfman, Norihisa Hanada, Mickey C.‐T. Hu, Yiyu Zou and Shilai Bao. Their work appears in journals such as Antioxidants, Environmental Toxicology, BMC Cancer, Cell and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.